The Development of Rapastinel (Formerly GLYX-13); A Rapid Acting and Long Lasting Antidepressant

BACKGROUND: Rapastinel (GLYX-13) is a NMDA receptor modulator with glycine-site partial agonist properties. It is a robust cognitive enhancer and shows rapid and long-lasting antidepressant properties in both animal models and in humans. METHODS: Rapastinel was derived from a monoclonal antibody, B6...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Curr Neuropharmacol
Main Authors: Moskal, Joseph R., Burgdorf, Jeffrey S., Stanton, Patric K., Kroes, Roger A., Disterhoft, John F., Burch, Ronald M., Khan, M. Amin
Formato: Artigo
Idioma:Inglês
Publicado em: Bentham Science Publishers 2017
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5327451/
https://ncbi.nlm.nih.gov/pubmed/26997507
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2174/1570159X14666160321122703
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados